Johnson & Johnson (JNJ) Reports Impressive Operational Sales Growth in Q2 2024
Wednesday, 17 July 2024, 10:41
Johnson & Johnson (JNJ) - Q2 2024 Earnings Report
Johnson & Johnson (NYSE: JNJ) released its financial results for the second quarter of 2024, highlighting significant shifts in key financial metrics.
Key Highlights:
- Reported Sales: Increased by 4.3% year-over-year to $22.4 billion
- Operational Sales Growth: Impressive at 6.6%
- Net Income: Declined by 12.8% to $4.6 billion
- EPS: Dropped 5.9% to $1.93
- Adjusted EPS: Rose by 10.2% to $2.82
The strong performance in adjusted EPS and surpassing of revenue and earnings estimates in Q2 2024 position Johnson & Johnson as a resilient player in the market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.